共 50 条
Arginine methyltransferase inhibitor 1 exhibits antitumor effects against cervical cancer in vitro and in vivo
被引:7
|作者:
Dong, Shu-Hong
[1
]
Wang, Xing
[2
]
Tian, San-Chun
[1
]
Ma, Neng-Qian
[2
]
Zhang, Xin-Yang
[2
]
Liu, Yapeng
[1
]
Zhang, Bao-Lai
[1
]
Wu, Yong-Jie
[1
]
机构:
[1] Lanzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Lanzhou, Gansu, Peoples R China
[2] Lanzhou Univ, Sch Med, Hosp 2, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou, Gansu, Peoples R China
来源:
关键词:
CELL LUNG-CANCER;
TUMOR-SUPPRESSOR;
PROTEIN;
METHYLATION;
PRMT5;
GROWTH;
EIF4E;
LYMPHOMA;
D O I:
10.1691/ph.2018.8365
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Protein arginine methyltransferase 5 (PRMT5), a type II PRMT, is highly expressed in several types of tumors including cervical cancer. Arginine methyltransferase inhibitor 1 (AMI-1) inhibits solid tumors by targeting PRMT5. However, the effect of AMI-1 on cervical cancer is still unknown. In this study, we provided the first evidence that AMI-1 reduced cervical cancer cell proliferation, colony formation and promoted cell apoptosis in vitro. Suppression of tumorigenicity was also confirmed in vivo. Mechanistic studies revealed that AMI-1 significantly reduced PRMT5 level in cells and mice xenografts model of cervical cancer. These results suggest that AMI-1 inhibits cervical cancer by type II PRMT5.
引用
收藏
页码:269 / 273
页数:5
相关论文